With over 60,000 transplants performed globally using stem cells from umbilical cord blood, the demand for life-saving ...

Cesarean section, a surgical procedure for delivering a baby through an incision made in the mother's abdomen, is generally ...

The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study The Company ...

Onward Medical announced today that a neurosurgeon performed the first human implant of its investigational ARC-IM lumbar ...

Detailed price information for Nurexone Biologic Inc (NRX-X) from The Globe and Mail including charting and trades.

Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

The team also addressed a long-standing puzzle in the blood stem cell field by showing that the greater regenerative potential of human umbilical cord-derived blood stem cells, compared with adult ...

Onward’s Arc-IM Lumbar Lead was used in its first human patient, the company said March 26. Dr. Jocelyn Bloch performed the ...

When Adam Rodman was a second-year medical student in the 2000s, he visited the library for a patient whose illness had left ...

Elle Yona went from performing as a competitive high school dancer and learning to drive, to being paralyzed from the neck down.

An international research team, led by scientists from Tel Aviv University and Sheba Medical Center, has unveiled an ...

Activating stem cells via molecular programming, rather than relying on random cell transplants, significantly enhances the success of regenerative treatments.